Suppr超能文献

通过DNA免疫中的抗原工程实现针对丙型肝炎病毒E2的T细胞反应的最佳诱导。

Optimal induction of T-cell responses against hepatitis C virus E2 by antigen engineering in DNA immunization.

作者信息

Youn Jin-Won, Park Su-Hyung, Cho Jae Ho, Sung Young Chul

机构信息

Laboratory of Cellular Immunology, Division of Molecular and Life Sciences, Pohang University of Science and Technology, Hyoja Dong, Pohang, Kyungbuk 790-784, Republic of Korea.

出版信息

J Virol. 2003 Nov;77(21):11596-602. doi: 10.1128/jvi.77.21.11596-11602.2003.

Abstract

Although DNA immunization is a safe and efficient method for inducing cellular immune responses, it generates relatively weak and slow immune responses. Here, we investigated the effect of hepatitis C virus (HCV) antigen modifications on the induction of T-cell responses in DNA immunization. It is likely that the strength of T-cell responses has an inverse relationship with the length of the insert DNA. Interestingly, a mixture of several plasmids carrying each gene induced a higher level of T-cell responses than a single plasmid expressing a long polyprotein. Moreover, the presence of a transmembrane domain in HCV E2 resulted in stronger T-cell responses against E2 protein than its absence. Taken together, our results indicate that the tailored modifications of DNA-encoded antigens are capable of optimizing the induction of T-cell responses which is required for eliminating the cells chronically infected with highly variable viruses such as HCV and human immunodeficiency virus.

摘要

尽管DNA免疫是诱导细胞免疫反应的一种安全有效的方法,但它产生的免疫反应相对较弱且缓慢。在此,我们研究了丙型肝炎病毒(HCV)抗原修饰对DNA免疫中T细胞反应诱导的影响。T细胞反应的强度可能与插入DNA的长度呈负相关。有趣的是,携带每个基因的几种质粒的混合物比表达长多聚蛋白的单个质粒诱导出更高水平的T细胞反应。此外,HCV E2中跨膜结构域的存在导致针对E2蛋白的T细胞反应比不存在时更强。综上所述,我们的结果表明,对DNA编码抗原进行定制修饰能够优化T细胞反应的诱导,而这对于清除长期感染高变异性病毒(如HCV和人类免疫缺陷病毒)的细胞是必需的。

相似文献

1
Optimal induction of T-cell responses against hepatitis C virus E2 by antigen engineering in DNA immunization.
J Virol. 2003 Nov;77(21):11596-602. doi: 10.1128/jvi.77.21.11596-11602.2003.
7
A candidate DNA vaccine elicits HCV specific humoral and cellular immune responses.
World J Gastroenterol. 2004 Sep 1;10(17):2488-92. doi: 10.3748/wjg.v10.i17.2488.

引用本文的文献

1
Molecular characterization and clinical epidemiology of HCV in District Dir (Lower), Pakistan.
Virusdisease. 2018 Sep;29(3):369-374. doi: 10.1007/s13337-018-0457-1. Epub 2018 May 17.
3
5
Development of hepatitis C virus vaccine using hepatitis B core antigen as immuno-carrier.
World J Gastroenterol. 2006 Dec 28;12(48):7774-8. doi: 10.3748/wjg.v12.i48.7774.
7
Therapeutic immunization for HIV.
Springer Semin Immunopathol. 2006 Nov;28(3):221-30. doi: 10.1007/s00281-006-0029-0. Epub 2006 Oct 10.

本文引用的文献

2
5
Strategies for designing and optimizing new generation vaccines.
Nat Rev Immunol. 2001 Dec;1(3):209-19. doi: 10.1038/35105075.
6
Cross-presentation in viral immunity and self-tolerance.
Nat Rev Immunol. 2001 Nov;1(2):126-34. doi: 10.1038/35100512.
7
Cross-priming as a predominant mechanism for inducing CD8(+) T cell responses in gene gun DNA immunization.
J Immunol. 2001 Nov 15;167(10):5549-57. doi: 10.4049/jimmunol.167.10.5549.
8
Immunoprophylaxis of hepatitis C virus infection.
Clin Liver Dis. 2001 Nov;5(4):1091-103. doi: 10.1016/s1089-3261(05)70211-7.
9
Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo.
J Immunol. 2001 May 15;166(10):6099-103. doi: 10.4049/jimmunol.166.10.6099.
10
Antigen levels and antibody titers after DNA vaccination.
J Pharm Sci. 2001 Apr;90(4):474-84. doi: 10.1002/1520-6017(200104)90:4<474::aid-jps1005>3.0.co;2-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验